Search Results - "Ino, Yoko"

Spatial analysis of accessibility to healthcare-related facilities in Tokyo Metropolis using geographic information systems.

Authors: Yamazaki, Tomofumi Ito, Seiichiro Ino, Yoko et al.

Source: PLoS ONE. 5/29/2026, Vol. 21 Issue 5, p1-22. 22p.

PHD3-VHL axis controls HIV-2 infection through oxygen-dependent hydroxylation and degradation of Vpx.

Authors: Miyakawa, Kei Tanaka, Kiho Ino, Yoko et al.

Source: PLoS Pathogens. 6/16/2025, Vol. 21 Issue 6, p1-21. 21p.

Identification of mouse soleus muscle proteins altered in response to changes in gravity loading.

Authors: Ino, Yoko Ohira, Takashi Kumagai, Ken et al.

Source: Scientific Reports. 9/22/2023, Vol. 13 Issue 1, p1-8. 8p.

Effects of microgravity exposure and fructo-oligosaccharide ingestion on the proteome of soleus and extensor digitorum longus muscles in developing mice.

Authors: Ohira, Takashi Ino, Yoko Kimura, Yayoi et al.

Source: NPJ Microgravity; 9/17/2021, Vol. 7 Issue 1, p1-11, 11p

Signal Detection Study Focusing on Differences in the Drug Delivery System of Oral 5-Aminosalicylate for Inflammatory Bowel Disease Using the Japanese Pharmacovigilance Database.

Authors: Noguchi, Yoshihiro Yamashita, Shuji Tamaki, Hirofumi et al.

Source: Pharmacoepidemiology (2813-0618). Mar2023, Vol. 2 Issue 1, p26-34. 9p.

Mass spectrometric characterization of proteins transferred from polyacrylamide gels to membrane filters.

Authors: Ino, Yoko Hirano, Hisashi

Source: FEBS Journal. Oct2011, Vol. 278 Issue 20, p3807-3814. 8p.

Impact of the increase in the number of community pharmacists on their geographical distribution in Japan: a retrospective survey.

Authors: Iguchi, Kazuhiro Ueyama, Midori Nishio, Hiroto et al.

Source: Journal of Pharmaceutical Policy & Practice. 12/8/2022, Vol. 15 Issue 1, p1-7. 7p.

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein.

Authors: Kimura, Yayoi Shin, Jihye Nakai, Yusuke et al.

Source: Viruses (1999-4915). Jul2022, Vol. 14 Issue 7, pN.PAG-N.PAG. 10p.

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease.

Authors: Yanagimachi, Masakatsu Fukuda, Sayaka Tanaka, Fumiko et al.

Source: PLoS ONE. 9/9/2021, Vol. 16 Issue 9, p1-10. 10p.

Quality of life assessment and cost‑utility analysis of initial chemotherapy for patients with non‑Hodgkin's lymphoma: A prospective analysis.

Authors: Tanaka, Kazuhide Yasuda, Masahiro Tachi, Tomoya et al.

Source: Oncology Letters. Sep2024, Vol. 28 Issue 3, pN.PAG-N.PAG. 1p.

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.

Authors: Kimura, Yayoi Nakai, Yusuke Shin, Jihye et al.

Source: Scientific Reports. 10/19/2021, Vol. 11 Issue 1, p1-9. 9p.

Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor.

Authors: Okuyama, Tomoko Shirakawa, Jun Tajima, Kazuki et al.

Source: International Journal of Molecular Sciences. Nov2020, Vol. 21 Issue 21, p7815. 1p.

Nuclear Pore Complex Protein Mediated Nuclear Localization of Dicer Protein in Human Cells.

Authors: Ando, Yoshinari Tomaru, Yasuhiro Morinaga, Ayako et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 8, p1-9. 9p.

Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis.

Authors: Kimura, Yayoi Yanagimachi, Masakatsu Ino, Yoko et al.

Source: Scientific Reports. 3/10/2017, p43732. 1p.